These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 22201294

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, Toniolo-Neto J, Drummond M, Weinstein M.
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [Abstract] [Full Text] [Related]

  • 4. [Cost-effectiveness of potential government fully-funded influenza vaccination in population with diabetes in China].
    Yang J, Yan H, Feng LZ, Yu HJ.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Oct 06; 53(10):1000-1006. PubMed ID: 31607045
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
    Thorrington D, van Leeuwen E, Ramsay M, Pebody R, Baguelin M.
    Vaccine; 2019 Apr 03; 37(15):2051-2056. PubMed ID: 30871927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Edoka I, Kohli-Lynch C, Fraser H, Hofman K, Tempia S, McMorrow M, Ramkrishna W, Lambach P, Hutubessy R, Cohen C.
    Vaccine; 2021 Jan 08; 39(2):412-422. PubMed ID: 33272702
    [Abstract] [Full Text] [Related]

  • 15. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
    Jahnz-Rózyk K.
    Pol Merkur Lekarski; 2010 Jul 08; 29(169):37-40. PubMed ID: 20712246
    [Abstract] [Full Text] [Related]

  • 16. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
    Newall AT, Scuffham PA, Kelly H, Harsley S, Macintyre CR.
    Vaccine; 2008 Apr 16; 26(17):2142-53. PubMed ID: 18343537
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness of increased influenza vaccination uptake against readmissions of major adverse cardiac events in the US.
    Peasah SK, Meltzer MI, Vu M, Moulia DL, Bridges CB.
    PLoS One; 2019 Apr 16; 14(4):e0213499. PubMed ID: 31034485
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
    de Boer PT, Backer JA, van Hoek AJ, Wallinga J.
    BMC Med; 2020 Jan 14; 18(1):11. PubMed ID: 31931789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.